T. Kasanen

发表

Anti-COX-2 autoantibody is a novel biomarker of immune aplastic anemia

S. Mustjoki, S. Ogawa, Xingmin Feng, 2022, Leukemia.

IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia

U. Olsson‐Strömberg, S. Mustjoki, M. Höglund, 2022, The Journal of clinical investigation.

Identification of three oligo‐/polysaccharide‐specific ligases in Yersinia enterocolitica

M. Skurnik, A. Rakin, M. Pajunen, 2012, Molecular microbiology.

Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia

H. Lähdesmäki, S. Mustjoki, J. Maciejewski, 2022, Nature Communications.

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia

U. Olsson‐Strömberg, S. Mustjoki, M. Höglund, 2016, Leukemia.

Disease Relapse After Tyrosine Kinase Inhibitor Treatment Discontinuation in Chronic Myeloid Leukaemia is Related to Both Low Number and Impaired Function of NK Cells

U. Olsson‐Strömberg, S. Mustjoki, S. Lehmann, 2014 .

Disease Relapse After TKI Discontinuation In CML Is Related Both To Low Number and Impaired Function Of NK-Cells:Data From Euro-SKI

U. Olsson‐Strömberg, S. Mustjoki, S. Lehmann, 2013 .

Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line

U. Olsson‐Strömberg, S. Mustjoki, J. Richter, 2019, Oncoimmunology.

Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation

H. Lähdesmäki, U. Olsson‐Strömberg, S. Mustjoki, 2023, Leukemia.